bpc-157 safety regulatory status fda The conversation around peptides just took a major step forward. The FDA's Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157, along with KPV, TB-500, and MOTS-C, to the 503A Bulks List FDA Compliance for Peptide Therapy

In support, recently BPC 157 increased the survival rate of cultured enteric neurons and the proliferation rate of cultured enteric glial cells (Wang et al., 2019)

The drug itself is coded separately using HCPCS code J3490 (unclassified drugs) with the appropriate NDC number for the specific tirzepatide product (Mounjaro or Zepbound)

Yang H, Zhou J, Wang J, et al

These check-ins ensure a safe, smooth recovery and optimal treatment outcomes

American Pharmacists Association (APhA) does not endorse, recommend, or support the use of unapproved compounded peptide products

Patients who have been previously prescribed a vitamin B12 injection